Loading report…
PFENYSESEC filerUS GAAPPharmaceutical PreparationsFiscal year ends December 31Reports in USD (US Dollar)
TTM Q2 FY2026 · ended Jun 28, 2026
Normalization v8 · calculations ratios_v2 · data version 1 · report generated Oct 11, 2026. Source: SEC EDGAR XBRL company facts.
Select a figure to see its source filing and exact value.
| Ratio | TTM Q3 FY2023 | TTM Q4 FY2023 | TTM Q1 FY2024 | TTM Q2 FY2024 | TTM Q3 FY2024 | TTM Q4 FY2024 | TTM Q1 FY2025 | TTM Q2 FY2025 | TTM Q3 FY2025 | TTM Q4 FY2025 | TTM Q1 FY2026 | TTM Q2 FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth | ||||||||||||
| Revenue growth | ||||||||||||
| Net income growth | —not available | —not available | ||||||||||
| Free cash flow growth | ||||||||||||
| Profitability | ||||||||||||
| Gross margin | ||||||||||||
| Cash flow & investment | ||||||||||||
| Free cash flow margin | ||||||||||||
| Balance sheet | ||||||||||||
| Debt / equity | ||||||||||||
| Working capital & shares | ||||||||||||
| Inventory growth | ||||||||||||
Select a ratio to see its formula, the exact inputs and periods used, and their source filings. — means an input is missing or the ratio is not meaningful (e.g. a negative denominator).
| Line item | TTM Q3 FY2023 | TTM Q4 FY2023 | TTM Q1 FY2024 | TTM Q2 FY2024 | TTM Q3 FY2024 | TTM Q4 FY2024 | TTM Q1 FY2025 | TTM Q2 FY2025 | TTM Q3 FY2025 | TTM Q4 FY2025 | TTM Q1 FY2026 | TTM Q2 FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | d (derived: Sum of 4 quarters FY2022 Q4 – FY2023 Q3) | d (derived: Sum of 4 quarters FY2023 Q1 – FY2023 Q4) | d (derived: Sum of 4 quarters FY2023 Q2 – FY2024 Q1) | d (derived: Sum of 4 quarters FY2023 Q3 – FY2024 Q2) | d (derived: Sum of 4 quarters FY2023 Q4 – FY2024 Q3) | d (derived: Sum of 4 quarters FY2024 Q1 – FY2024 Q4) | d (derived: Sum of 4 quarters FY2024 Q2 – FY2025 Q1) | d (derived: Sum of 4 quarters FY2024 Q3 – FY2025 Q2) | d (derived: Sum of 4 quarters FY2024 Q4 – FY2025 Q3) | d (derived: Sum of 4 quarters FY2025 Q1 – FY2025 Q4) | d (derived: Sum of 4 quarters FY2025 Q2 – FY2026 Q1) | d (derived: Sum of 4 quarters FY2025 Q3 – FY2026 Q2) |
| Cost of revenue | d (derived: Sum of 4 quarters FY2022 Q4 – FY2023 Q3) | d (derived: Sum of 4 quarters FY2023 Q1 – FY2023 Q4) | d (derived: Sum of 4 quarters FY2023 Q2 – FY2024 Q1) | d (derived: Sum of 4 quarters FY2023 Q3 – FY2024 Q2) | d (derived: Sum of 4 quarters FY2023 Q4 – FY2024 Q3) | |||||||
| Gross profit | d (derived: Sum of 4 quarters FY2022 Q4 – FY2023 Q3) | d (derived: Sum of 4 quarters FY2023 Q1 – FY2023 Q4) | d (derived: Sum of 4 quarters FY2023 Q2 – FY2024 Q1) | d (derived: Sum of 4 quarters FY2023 Q3 – FY2024 Q2) | d (derived: Sum of 4 quarters FY2023 Q4 – FY2024 Q3) | |||||||
| Research & development | d (derived: Sum of 4 quarters FY2022 Q4 – FY2023 Q3) | d (derived: Sum of 4 quarters FY2023 Q1 – FY2023 Q4) | d (derived: Sum of 4 quarters FY2023 Q2 – FY2024 Q1) | d (derived: Sum of 4 quarters FY2023 Q3 – FY2024 Q2) | d (derived: Sum of 4 quarters FY2023 Q4 – FY2024 Q3) | |||||||
| Selling, general & administrative | d (derived: Sum of 4 quarters FY2022 Q4 – FY2023 Q3) | d (derived: Sum of 4 quarters FY2023 Q1 – FY2023 Q4) | d (derived: Sum of 4 quarters FY2023 Q2 – FY2024 Q1) | d (derived: Sum of 4 quarters FY2023 Q3 – FY2024 Q2) | d (derived: Sum of 4 quarters FY2023 Q4 – FY2024 Q3) | |||||||
| Net interest income | d (derived: Sum of 4 quarters FY2022 Q4 – FY2023 Q3) | d (derived: Sum of 4 quarters FY2023 Q1 – FY2023 Q4) | d (derived: Sum of 4 quarters FY2023 Q2 – FY2024 Q1) | d (derived: Sum of 4 quarters FY2023 Q3 – FY2024 Q2) | d (derived: Sum of 4 quarters FY2023 Q4 – FY2024 Q3) | |||||||
| Interest expense | d (derived: Sum of 4 quarters FY2022 Q4 – FY2023 Q3) | d (derived: Sum of 4 quarters FY2023 Q1 – FY2023 Q4) | d (derived: Sum of 4 quarters FY2023 Q2 – FY2024 Q1) | d (derived: Sum of 4 quarters FY2023 Q3 – FY2024 Q2) | d (derived: Sum of 4 quarters FY2023 Q4 – FY2024 Q3) | |||||||
| Income before taxes | d (derived: Sum of 4 quarters FY2022 Q4 – FY2023 Q3) | d (derived: Sum of 4 quarters FY2023 Q1 – FY2023 Q4) | d (derived: Sum of 4 quarters FY2023 Q2 – FY2024 Q1) | d (derived: Sum of 4 quarters FY2023 Q3 – FY2024 Q2) | d (derived: Sum of 4 quarters FY2023 Q4 – FY2024 Q3) | |||||||
| Income tax expense | d (derived: Sum of 4 quarters FY2022 Q4 – FY2023 Q3) | d (derived: Sum of 4 quarters FY2023 Q1 – FY2023 Q4) | d (derived: Sum of 4 quarters FY2023 Q2 – FY2024 Q1) | d (derived: Sum of 4 quarters FY2023 Q3 – FY2024 Q2) | d (derived: Sum of 4 quarters FY2023 Q4 – FY2024 Q3) | |||||||
| Net income | d (derived: Sum of 4 quarters FY2022 Q4 – FY2023 Q3) | d (derived: Sum of 4 quarters FY2023 Q1 – FY2023 Q4) | d (derived: Sum of 4 quarters FY2023 Q2 – FY2024 Q1) | d (derived: Sum of 4 quarters FY2023 Q3 – FY2024 Q2) | d (derived: Sum of 4 quarters FY2023 Q4 – FY2024 Q3) |
Select any figure for its source filing and exact value. d derived by FinSavoir (e.g. Q4 = fiscal year − nine months) · r restated in a later filing · s adjusted for a stock split · — not reported for that period · withheld = failed a data-quality check.
| Line item | TTM Q3 FY2023 | TTM Q4 FY2023 | TTM Q1 FY2024 | TTM Q2 FY2024 | TTM Q3 FY2024 | TTM Q4 FY2024 | TTM Q1 FY2025 | TTM Q2 FY2025 | TTM Q3 FY2025 | TTM Q4 FY2025 | TTM Q1 FY2026 | TTM Q2 FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & cash equivalents |
| Line item | TTM Q3 FY2023 | TTM Q4 FY2023 | TTM Q1 FY2024 | TTM Q2 FY2024 | TTM Q3 FY2024 | TTM Q4 FY2024 | TTM Q1 FY2025 | TTM Q2 FY2025 | TTM Q3 FY2025 | TTM Q4 FY2025 | TTM Q1 FY2026 | TTM Q2 FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | d (derived: Sum of 4 quarters FY2022 Q4 – FY2023 Q3) |
Mechanical forecasts of reported revenue from PFIZER INC's own SEC filings. Each was recorded in FinSavoir's prediction ledger when it was issued and is never edited; it will be scored when the company reports the period. They say nothing about business prospects beyond the past pattern of revenue.
Each forecast in the chart is listed below with a link to its ledger record.
| Target | Model | Forecast | 80% prediction interval | vs “same as last year” | Ledger record |
|---|---|---|---|---|---|
| FY20261 year ahead · ends Dec 31, 2026 | Same as last yearReference (benchmark) | $62.6B | Not shown: no evaluated error range | — | Record |
| Straight-line trend (legacy)Benchmark | $68.2B | Not shown: no evaluated error range | +9.0% | Record | |
| Damped trend (exponential smoothing)Challenger (not promoted) | $65.2B | Not shown: no evaluated error range |
naive_last_v1). Next year's revenue equals the latest year's.f7b9cd59-57b6-487c-8ddb-2b370202df3c in the ledger. It will be compared with the revenue first reported for FY2026, and with any later restatement.Every forecast FinSavoir issued for this company, newest first (the latest 19 of 19 are listed; each links to its full ledger record). A forecast is scored against the revenue first reported in the company's filing for that period, once that filing exists; a period ending is not enough. Superseded forecasts (replaced by a newer one for the same period and model) are kept unchanged and still scored.
How the models were evaluated, and results across all companies →
Warning: Four quarters don't add up to the fiscal year · Net income
Net income: the four quarters add up to 8,907,000,000 but the fiscal year is 9,159,000,000 (more than 0.5% apart).
Affected period: TTM Q4 FY2020
Warning: Four quarters don't add up to the fiscal year · Operating cash flow
Operating cash flow: the four quarters add up to 16,058,000,000 but the fiscal year is 16,192,000,000 (more than 0.5% apart).
Affected period: TTM Q4 FY2016
Warning: Four quarters don't add up to the fiscal year · Revenue
Four quarters don't add up to the fiscal year in 5 periods. Example: Revenue: the four quarters add up to 67,264,000,000 but the fiscal year is 65,165,000,000 (more than 0.5% apart).
Affected periods: TTM Q4 FY2010, TTM Q4 FY2011, TTM Q4 FY2012, TTM Q4 FY2020, TTM Q4 FY2023
Adjusted for a stock split · Diluted EPS
Diluted EPS was retroactively adjusted for a stock split (×0.6667); first reported 0.39, now 0.26.
Q3 FY2020
Annual figure restated; quarters not re-reported · Net income
Net income: the four quarters add up to the fiscal year as first reported (16,273,000,000); the annual figure was later restated to 16,026,000,000 and the quarters were not re-reported.
TTM Q4 FY2019
Annual figure restated; quarters not re-reported · Operating cash flow · 5 periods
Annual figure restated; quarters not re-reported in 5 periods. Example: Operating cash flow: the four quarters add up to the fiscal year as first reported (17,054,000,000); the annual figure was later restated to 16,746,000,000 and the quarters were not re-reported.
TTM Q4 FY2012, TTM Q4 FY2013, TTM Q4 FY2014, TTM Q4 FY2015, TTM Q4 FY2017
Annual figure restated; quarters not re-reported · Revenue · 3 periods
Annual figure restated; quarters not re-reported in 3 periods. Example: Revenue: the four quarters add up to the fiscal year as first reported (50,009,000,000); the annual figure was later restated to 49,269,000,000 and the quarters were not re-reported.
TTM Q4 FY2009, TTM Q4 FY2018, TTM Q4 FY2019
Restated in a later filing · Accounts receivable · 6 periods
Restated in a later filing in 6 periods. Example: Accounts receivable was restated from 14,612,000,000 to 13,380,000,000.
FY2010, FY2011, FY2012, FY2014, FY2019, FY2023
Restated in a later filing · Capital expenditure · 4 periods
Restated in a later filing in 4 periods. Example: Capital expenditure was restated from 2,042,000,000 to 1,984,000,000.
FY2018, FY2019, Q1 FY2020, FY2020
Restated in a later filing · Cash & cash equivalents · 4 periods
Restated in a later filing in 4 periods. Example: Cash & cash equivalents was restated from 3,539,000,000 to 3,182,000,000.
FY2011, FY2012, Q1 FY2013, FY2019
Restated in a later filing · Cost of revenue · 21 periods
Restated in a later filing in 21 periods. Example: Cost of revenue was restated from 8,888,000,000 to 8,459,000,000.
FY2009, Q1 FY2010, Q2 FY2010, Q3 FY2010, FY2010, Q2 FY2011, Q3 FY2011, FY2011, Q1 FY2012, Q2 FY2012, Q3 FY2012, FY2012, Q1 FY2013, FY2018, FY2019, Q1 FY2020, Q2 FY2020, Q3 FY2020, FY2020, Q1 FY2021, Q2 FY2021
Restated in a later filing · Current assets · 4 periods
Restated in a later filing in 4 periods. Example: Current assets was restated from 60,468,000,000 to 61,013,000,000.
FY2010, FY2011, FY2012, FY2014
Restated in a later filing · Current liabilities · 2 periods
Restated in a later filing in 2 periods. Example: Current liabilities was restated from 28,069,000,000 to 28,909,000,000.
FY2011, FY2012
Restated in a later filing · Depreciation & amortization · 5 periods
Restated in a later filing in 5 periods. Example: Depreciation & amortization was restated from 8,487,000,000 to 8,399,000,000.
FY2010, FY2011, Q1 FY2012, FY2012, FY2019
Restated in a later filing · Diluted EPS · 5 periods
Restated in a later filing in 5 periods. Example: Diluted EPS was restated from 3 to 3.
Q3 FY2016, FY2019, Q1 FY2020, Q2 FY2020, FY2020
Restated in a later filing · Income before taxes · 17 periods
Restated in a later filing in 17 periods. Example: Income before taxes was restated from 9,282,000,000 to 9,471,000,000.
Q1 FY2010, FY2010, Q2 FY2011, Q3 FY2011, FY2011, Q1 FY2012, Q2 FY2012, Q3 FY2012, FY2012, Q1 FY2013, FY2018, FY2019, Q1 FY2020, Q2 FY2020, Q3 FY2020, FY2020, Q2 FY2021
Restated in a later filing · Income tax expense · 24 periods
Restated in a later filing in 24 periods. Example: Income tax expense was restated from 2,197,000,000 to 2,145,000,000.
FY2009, Q1 FY2010, Q2 FY2010, Q3 FY2010, FY2010, Q2 FY2011, Q3 FY2011, FY2011, Q1 FY2012, Q2 FY2012, Q3 FY2012, FY2012, Q1 FY2013, Q1 FY2016, Q2 FY2016, Q3 FY2016, FY2018, FY2019, Q1 FY2020, Q2 FY2020, Q3 FY2020, FY2020, Q2 FY2021, Q3 FY2021
Restated in a later filing · Interest expense · 3 periods
Restated in a later filing in 3 periods. Example: Interest expense was restated from 391,000,000 to 371,000,000.
Q1 FY2013, Q2 FY2020, Q3 FY2020
Restated in a later filing · Inventory · 4 periods
Restated in a later filing in 4 periods. Example: Inventory was restated from 8,405,000,000 to 8,275,000,000.
FY2010, FY2011, FY2012, FY2019
Restated in a later filing · Net income · 8 periods
Restated in a later filing in 8 periods. Example: Net income was restated from 16,273,000,000 to 16,026,000,000.
Q1 FY2016, Q2 FY2016, Q3 FY2016, FY2019, Q1 FY2020, Q2 FY2020, Q3 FY2020, FY2020
Restated in a later filing · Net interest income · 2 periods
Restated in a later filing in 2 periods. Example: Net interest income was restated from -353,000,000 to -348,000,000.
Q2 FY2020, Q3 FY2020
Restated in a later filing · Operating cash flow · 8 periods
Restated in a later filing in 8 periods. Example: Operating cash flow was restated from 17,054,000,000 to 16,746,000,000.
FY2012, Q1 FY2013, FY2014, Q1 FY2015, FY2015, Q1 FY2016, FY2016, FY2017
Restated in a later filing · Research & development · 17 periods
Restated in a later filing in 17 periods. Example: Research & development was restated from 9,413,000,000 to 9,483,000,000.
FY2010, Q3 FY2011, FY2011, Q2 FY2012, Q3 FY2012, FY2012, Q1 FY2013, FY2018, FY2019, Q1 FY2020, Q2 FY2020, Q3 FY2020, FY2020, Q1 FY2021, Q2 FY2021, Q3 FY2021, FY2021
Restated in a later filing · Revenue · 23 periods
Restated in a later filing in 23 periods. Example: Revenue was restated from 50,009,000,000 to 49,269,000,000.
FY2009, Q1 FY2010, Q2 FY2010, Q3 FY2010, FY2010, Q2 FY2011, Q3 FY2011, FY2011, Q1 FY2012, Q2 FY2012, Q3 FY2012, FY2012, Q1 FY2013, FY2018, FY2019, Q1 FY2020, Q2 FY2020, Q3 FY2020, FY2022, Q1 FY2023, Q2 FY2023, Q3 FY2023, FY2023
Restated in a later filing · Selling, general & administrative · 18 periods
Restated in a later filing in 18 periods. Example: Selling, general & administrative was restated from 14,875,000,000 to 14,752,000,000.
FY2009, Q1 FY2010, Q2 FY2010, Q3 FY2010, FY2010, Q2 FY2011, Q3 FY2011, FY2011, Q1 FY2012, Q2 FY2012, Q3 FY2012, FY2012, Q1 FY2013, FY2018, FY2019, Q1 FY2020, Q2 FY2020, Q3 FY2020
Restated in a later filing · Total assets
Total assets was restated from 169,274,000,000 to 167,566,000,000.
FY2014
Restated in a later filing · Total liabilities
Total liabilities was restated from 97,652,000,000 to 95,944,000,000.
FY2014
Restated in a later filing · Total liabilities & equity
Total liabilities & equity was restated from 169,274,000,000 to 167,566,000,000.
FY2014
Latest annual report
10-K · fiscal year ended Dec 31, 2025 · filed Feb 26, 2026
| Net margin |
|---|
| Return on equity |
|---|
| Return on assets |
|---|
| Effective tax rate | —not available | —not available |
|---|
| FCF conversion | —not available | —not available |
|---|
| CapEx as % of revenue |
|---|
| R&D as % of revenue |
|---|
| SG&A as % of revenue |
|---|
| Debt / assets |
|---|
| Liabilities / assets |
|---|
| Current ratio |
|---|
| Equity / assets |
|---|
| Receivables growth |
|---|
| d (derived: Sum of 4 quarters FY2024 Q2 – FY2025 Q1) |
| d (derived: Sum of 4 quarters FY2024 Q3 – FY2025 Q2) |
| d (derived: Sum of 4 quarters FY2024 Q4 – FY2025 Q3) |
| d (derived: Sum of 4 quarters FY2025 Q1 – FY2025 Q4) |
| d (derived: Sum of 4 quarters FY2025 Q2 – FY2026 Q1) |
| d (derived: Sum of 4 quarters FY2025 Q3 – FY2026 Q2) |
| d (derived: Sum of 4 quarters FY2024 Q2 – FY2025 Q1) |
| d (derived: Sum of 4 quarters FY2024 Q3 – FY2025 Q2) |
| d (derived: Sum of 4 quarters FY2024 Q4 – FY2025 Q3) |
| d (derived: Sum of 4 quarters FY2025 Q1 – FY2025 Q4) |
| d (derived: Sum of 4 quarters FY2025 Q2 – FY2026 Q1) |
| d (derived: Sum of 4 quarters FY2025 Q3 – FY2026 Q2) |
| d (derived: Sum of 4 quarters FY2024 Q2 – FY2025 Q1) |
| d (derived: Sum of 4 quarters FY2024 Q3 – FY2025 Q2) |
| d (derived: Sum of 4 quarters FY2024 Q4 – FY2025 Q3) |
| d (derived: Sum of 4 quarters FY2025 Q1 – FY2025 Q4) |
| d (derived: Sum of 4 quarters FY2025 Q2 – FY2026 Q1) |
| d (derived: Sum of 4 quarters FY2025 Q3 – FY2026 Q2) |
| d (derived: Sum of 4 quarters FY2024 Q2 – FY2025 Q1) |
| d (derived: Sum of 4 quarters FY2024 Q3 – FY2025 Q2) |
| d (derived: Sum of 4 quarters FY2024 Q4 – FY2025 Q3) |
| d (derived: Sum of 4 quarters FY2025 Q1 – FY2025 Q4) |
| d (derived: Sum of 4 quarters FY2025 Q2 – FY2026 Q1) |
| d (derived: Sum of 4 quarters FY2025 Q3 – FY2026 Q2) |
| d (derived: Sum of 4 quarters FY2024 Q2 – FY2025 Q1) |
| d (derived: Sum of 4 quarters FY2024 Q3 – FY2025 Q2) |
| d (derived: Sum of 4 quarters FY2024 Q4 – FY2025 Q3) |
| d (derived: Sum of 4 quarters FY2025 Q1 – FY2025 Q4) |
| d (derived: Sum of 4 quarters FY2025 Q2 – FY2026 Q1) |
| d (derived: Sum of 4 quarters FY2025 Q3 – FY2026 Q2) |
| d (derived: Sum of 4 quarters FY2024 Q2 – FY2025 Q1) |
| d (derived: Sum of 4 quarters FY2024 Q3 – FY2025 Q2) |
| d (derived: Sum of 4 quarters FY2024 Q4 – FY2025 Q3) |
| d (derived: Sum of 4 quarters FY2025 Q1 – FY2025 Q4) |
| d (derived: Sum of 4 quarters FY2025 Q2 – FY2026 Q1) |
| d (derived: Sum of 4 quarters FY2025 Q3 – FY2026 Q2) |
| d (derived: Sum of 4 quarters FY2024 Q2 – FY2025 Q1) |
| d (derived: Sum of 4 quarters FY2024 Q3 – FY2025 Q2) |
| d (derived: Sum of 4 quarters FY2024 Q4 – FY2025 Q3) |
| d (derived: Sum of 4 quarters FY2025 Q1 – FY2025 Q4) |
| d (derived: Sum of 4 quarters FY2025 Q2 – FY2026 Q1) |
| d (derived: Sum of 4 quarters FY2025 Q3 – FY2026 Q2) |
| d (derived: Sum of 4 quarters FY2024 Q2 – FY2025 Q1) |
| d (derived: Sum of 4 quarters FY2024 Q3 – FY2025 Q2) |
| d (derived: Sum of 4 quarters FY2024 Q4 – FY2025 Q3) |
| d (derived: Sum of 4 quarters FY2025 Q1 – FY2025 Q4) |
| d (derived: Sum of 4 quarters FY2025 Q2 – FY2026 Q1) |
| d (derived: Sum of 4 quarters FY2025 Q3 – FY2026 Q2) |
| d (derived: Sum of 4 quarters FY2024 Q2 – FY2025 Q1) |
| d (derived: Sum of 4 quarters FY2024 Q3 – FY2025 Q2) |
| d (derived: Sum of 4 quarters FY2024 Q4 – FY2025 Q3) |
| d (derived: Sum of 4 quarters FY2025 Q1 – FY2025 Q4) |
| d (derived: Sum of 4 quarters FY2025 Q2 – FY2026 Q1) |
| d (derived: Sum of 4 quarters FY2025 Q3 – FY2026 Q2) |
| Short-term investments |
|---|
| Accounts receivable |
|---|
| Inventory |
|---|
| Current assets |
|---|
| Total assets |
|---|
| Current liabilities |
|---|
| Total debt | d (derived: debt current + long term debt noncurrent) | d (derived: debt current + long term debt noncurrent) | d (derived: debt current + long term debt noncurrent) | d (derived: debt current + long term debt noncurrent) | d (derived: debt current + long term debt noncurrent) | d (derived: debt current + long term debt noncurrent) | d (derived: debt current + long term debt noncurrent) | d (derived: debt current + long term debt noncurrent) | d (derived: debt current + long term debt noncurrent) | d (derived: debt current + long term debt noncurrent) | d (derived: debt current + long term debt noncurrent) | d (derived: debt current + long term debt noncurrent) |
|---|
| Total liabilities |
|---|
| Shareholders' equity |
|---|
Select any figure for its source filing and exact value. d derived by FinSavoir (e.g. Q4 = fiscal year − nine months) · r restated in a later filing · s adjusted for a stock split · — not reported for that period · withheld = failed a data-quality check.
| d (derived: Sum of 4 quarters FY2023 Q2 – FY2024 Q1) |
| d (derived: Sum of 4 quarters FY2023 Q3 – FY2024 Q2) |
| d (derived: Sum of 4 quarters FY2023 Q4 – FY2024 Q3) |
| d (derived: Sum of 4 quarters FY2024 Q1 – FY2024 Q4) |
| d (derived: Sum of 4 quarters FY2024 Q2 – FY2025 Q1) |
| d (derived: Sum of 4 quarters FY2024 Q3 – FY2025 Q2) |
| d (derived: Sum of 4 quarters FY2024 Q4 – FY2025 Q3) |
| d (derived: Sum of 4 quarters FY2025 Q1 – FY2025 Q4) |
| d (derived: Sum of 4 quarters FY2025 Q2 – FY2026 Q1) |
| d (derived: Sum of 4 quarters FY2025 Q3 – FY2026 Q2) |
| Capital expenditure | d (derived: Sum of 4 quarters FY2022 Q4 – FY2023 Q3) | d (derived: Sum of 4 quarters FY2023 Q1 – FY2023 Q4) | d (derived: Sum of 4 quarters FY2023 Q2 – FY2024 Q1) | d (derived: Sum of 4 quarters FY2023 Q3 – FY2024 Q2) | d (derived: Sum of 4 quarters FY2023 Q4 – FY2024 Q3) | d (derived: Sum of 4 quarters FY2024 Q1 – FY2024 Q4) | d (derived: Sum of 4 quarters FY2024 Q2 – FY2025 Q1) | d (derived: Sum of 4 quarters FY2024 Q3 – FY2025 Q2) | d (derived: Sum of 4 quarters FY2024 Q4 – FY2025 Q3) | d (derived: Sum of 4 quarters FY2025 Q1 – FY2025 Q4) | d (derived: Sum of 4 quarters FY2025 Q2 – FY2026 Q1) | d (derived: Sum of 4 quarters FY2025 Q3 – FY2026 Q2) |
|---|
| Free cash flow | d (derived: Operating cash flow − capital expenditure (TTM)) | d (derived: Operating cash flow − capital expenditure (TTM)) | d (derived: Operating cash flow − capital expenditure (TTM)) | d (derived: Operating cash flow − capital expenditure (TTM)) | d (derived: Operating cash flow − capital expenditure (TTM)) | d (derived: Operating cash flow − capital expenditure (TTM)) | d (derived: Operating cash flow − capital expenditure (TTM)) | d (derived: Operating cash flow − capital expenditure (TTM)) | d (derived: Operating cash flow − capital expenditure (TTM)) | d (derived: Operating cash flow − capital expenditure (TTM)) | d (derived: Operating cash flow − capital expenditure (TTM)) | d (derived: Operating cash flow − capital expenditure (TTM)) |
|---|
| Depreciation & amortization | d (derived: Sum of 4 quarters FY2022 Q4 – FY2023 Q3) | d (derived: Sum of 4 quarters FY2023 Q1 – FY2023 Q4) | d (derived: Sum of 4 quarters FY2023 Q2 – FY2024 Q1) | d (derived: Sum of 4 quarters FY2023 Q3 – FY2024 Q2) | d (derived: Sum of 4 quarters FY2023 Q4 – FY2024 Q3) | d (derived: Sum of 4 quarters FY2024 Q1 – FY2024 Q4) | d (derived: Sum of 4 quarters FY2024 Q2 – FY2025 Q1) | d (derived: Sum of 4 quarters FY2024 Q3 – FY2025 Q2) | d (derived: Sum of 4 quarters FY2024 Q4 – FY2025 Q3) | d (derived: Sum of 4 quarters FY2025 Q1 – FY2025 Q4) | d (derived: Sum of 4 quarters FY2025 Q2 – FY2026 Q1) | d (derived: Sum of 4 quarters FY2025 Q3 – FY2026 Q2) |
|---|
| Share repurchases | d (derived: Sum of 4 quarters FY2022 Q4 – FY2023 Q3) | d (derived: Sum of 4 quarters FY2023 Q1 – FY2023 Q4) | —not reported for this period | —not reported for this period | —not reported for this period | —not reported for this period | —not reported for this period | —not reported for this period | —not reported for this period | —not reported for this period | —not reported for this period | —not reported for this period |
|---|
Select any figure for its source filing and exact value. d derived by FinSavoir (e.g. Q4 = fiscal year − nine months) · r restated in a later filing · s adjusted for a stock split · — not reported for that period · withheld = failed a data-quality check.
| +4.1% |
| Record |
| Average growth (drift)Challenger (not promoted) | $53.3B | Not shown: no evaluated error range | −14.8% | Record |
| Damped recent growthChallenger (not promoted) | $62.3B | Not shown: no evaluated error range | −0.4% | Record |
| FY20272 years ahead · ends Dec 31, 2027 | Same as last yearReference (benchmark) | $62.6B | Not shown: no evaluated error range | — | Record |
|---|---|---|---|---|---|
| Straight-line trend (legacy)Benchmark | $69.5B | Not shown: no evaluated error range | +11.1% | Record | |
| Damped trend (exponential smoothing)Challenger (not promoted) | $65.4B | Not shown: no evaluated error range | +4.5% | Record | |
| Average growth (drift)Challenger (not promoted) | $45.4B | Not shown: no evaluated error range | −27.4% | Record | |
| Damped recent growthChallenger (not promoted) | $62.1B | Not shown: no evaluated error range | −0.8% | Record |
Each forecast in the chart is listed below with a link to its ledger record.
| Target | Model | Forecast | 80% prediction interval | vs “same as last quarter” | Ledger record |
|---|---|---|---|---|---|
| Q4 FY20262 quarters ahead · ends Dec 28, 2026 | Same as last quarterReference (benchmark) | $15.0B | Not shown: no evaluated error range | — | Record |
| Same quarter last year × trailing growthChallenger (not promoted) | $17.5B | Not shown: no evaluated error range | +16.5% | Record | |
| Same quarter last yearChallenger (not promoted) | $17.6B | Not shown: no evaluated error range | +16.8% | Record | |
| Q1 FY20273 quarters ahead · ends Mar 29, 2027 | Same as last quarterReference (benchmark) | $15.0B | Not shown: no evaluated error range | — | Record |
| Same quarter last year × trailing growthChallenger (not promoted) | $14.4B | Not shown: no evaluated error range | −4.1% | Record | |
| Same quarter last yearChallenger (not promoted) | $14.5B | Not shown: no evaluated error range | −3.9% | Record | |
| Q2 FY20274 quarters ahead · ends Jun 28, 2027 | Same as last quarterReference (benchmark) | $15.0B | Not shown: no evaluated error range | — | Record |
| Same quarter last year × trailing growthChallenger (not promoted) | $15.0B | Not shown: no evaluated error range | −0.2% | Record | |
| Same quarter last yearChallenger (not promoted) | $15.0B | Not shown: no evaluated error range | 0.0% | Record |
naive_last_q_v1). Every future quarter equals the latest quarter.24de4f95-046b-49b9-aaf0-26d57aeee3fd in the ledger. It will be compared with the revenue first reported for Q4 FY2026, and with any later restatement.| Q2 FY2027 |
| Same quarter last year × trailing growth |
| $15.0B |
| Awaiting period end |
| — |
| — |
| — |
| Record |
| Oct 11, 2026 | Q1 FY2027 | Same as last quarter | $15.0B | Awaiting period end | — | — | — | Record |
| Oct 11, 2026 | Q1 FY2027 | Same quarter last year | $14.5B | Awaiting period end | — | — | — | Record |
| Oct 11, 2026 | Q1 FY2027 | Same quarter last year × trailing growth | $14.4B | Awaiting period end | — | — | — | Record |
| Oct 11, 2026 | Q4 FY2026 | Same as last quarter | $15.0B | Awaiting period end | — | — | — | Record |
| Oct 11, 2026 | Q4 FY2026 | Same quarter last year | $17.6B | Awaiting period end | — | — | — | Record |
| Oct 11, 2026 | Q4 FY2026 | Same quarter last year × trailing growth | $17.5B | Awaiting period end | — | — | — | Record |
| Oct 11, 2026 | FY2027 | Same as last year | $62.6B | Awaiting period end | — | — | — | Record |
| Oct 11, 2026 | FY2027 | Straight-line trend (legacy) | $69.5B | Awaiting period end | — | — | — | Record |
| Oct 11, 2026 | FY2027 | Average growth (drift) | $45.4B | Awaiting period end | — | — | — | Record |
| Oct 11, 2026 | FY2027 | Damped recent growth | $62.1B | Awaiting period end | — | — | — | Record |
| Oct 11, 2026 | FY2027 | Damped trend (exponential smoothing) | $65.4B | Awaiting period end | — | — | — | Record |
| Oct 11, 2026 | FY2026 | Straight-line trend (legacy) | $68.2B | Awaiting period end | — | — | — | Record |
| Oct 11, 2026 | FY2026 | Same as last year | $62.6B | Awaiting period end | — | — | — | Record |
| Oct 11, 2026 | FY2026 | Average growth (drift) | $53.3B | Awaiting period end | — | — | — | Record |
| Oct 11, 2026 | FY2026 | Damped recent growth | $62.3B | Awaiting period end | — | — | — | Record |
| Oct 11, 2026 | FY2026 | Damped trend (exponential smoothing) | $65.2B | Awaiting period end | — | — | — | Record |